137 related articles for article (PubMed ID: 27624558)
1. The enhanced atorvastatin hepatotoxicity in diabetic rats was partly attributed to the upregulated hepatic Cyp3a and SLCO1B1.
Shu N; Hu M; Ling Z; Liu P; Wang F; Xu P; Zhong Z; Sun B; Zhang M; Li F; Xie Q; Liu X; Liu L
Sci Rep; 2016 Sep; 6():33072. PubMed ID: 27624558
[TBL] [Abstract][Full Text] [Related]
2. Prediction of Atorvastatin Pharmacokinetics in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats Using a Semiphysiologically Based Pharmacokinetic Model Involving Both Enzymes and Transporters.
Wang Z; Yang H; Xu J; Zhao K; Chen Y; Liang L; Li P; Chen N; Geng D; Zhang X; Liu X; Liu L
Drug Metab Dispos; 2019 Oct; 47(10):1066-1079. PubMed ID: 31399507
[TBL] [Abstract][Full Text] [Related]
3. Decreased exposure of atorvastatin in diabetic rats partly due to induction of hepatic Cyp3a and Oatp2.
Shu N; Hu M; Liu C; Zhang M; Ling Z; Zhang J; Xu P; Zhong Z; Chen Y; Liu L; Liu X
Xenobiotica; 2016 Oct; 46(10):875-81. PubMed ID: 26864241
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin Induces Hepatotoxicity in Diabetic Rats via Oxidative Stress, Inflammation, and Anti-Apoptotic Pathway.
Zeng H; Liu Z
Med Sci Monit; 2019 Aug; 25():6165-6173. PubMed ID: 31420530
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity of luteolin in primary rat hepatocytes: the role of CYP3A-mediated ortho-benzoquinone metabolite formation and glutathione depletion.
Shi F; Zhao P; Li X; Pan H; Ma S; Ding L
J Appl Toxicol; 2015 Nov; 35(11):1372-80. PubMed ID: 25612170
[TBL] [Abstract][Full Text] [Related]
6. In vitro evaluation of hepatotoxic drugs in human hepatocytes from multiple donors: Identification of P450 activity as a potential risk factor for drug-induced liver injuries.
Utkarsh D; Loretz C; Li AP
Chem Biol Interact; 2016 Aug; 255():12-22. PubMed ID: 26718876
[TBL] [Abstract][Full Text] [Related]
7. CYP3A Activation and Glutathione Depletion Aggravate Emodin-Induced Liver Injury.
Jiang LL; Jiang Y; Zhao DS; Fan YX; Yu Q; Li P; Li HJ
Chem Res Toxicol; 2018 Oct; 31(10):1052-1060. PubMed ID: 30203651
[TBL] [Abstract][Full Text] [Related]
8. RAT CYP3A and CYP2B1/2 were not associated with nevirapine-induced hepatotoxicity.
Walubo A; Barr S; Abraham AM
Methods Find Exp Clin Pharmacol; 2006 Sep; 28(7):423-31. PubMed ID: 17003847
[TBL] [Abstract][Full Text] [Related]
9. Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism.
He YJ; Zhang W; Chen Y; Guo D; Tu JH; Xu LY; Tan ZR; Chen BL; Li Z; Zhou G; Yu BN; Kirchheiner J; Zhou HH
Clin Chim Acta; 2009 Jul; 405(1-2):49-52. PubMed ID: 19374892
[TBL] [Abstract][Full Text] [Related]
10. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
11. Evaluating the Role of Drug Metabolism and Reactive Intermediates in Trazodone-Induced Cytotoxicity toward Freshly-Isolated Rat Hepatocytes.
Najibi A; Heidari R; Zarifi J; Jamshidzadeh A; Firoozabadi N; Niknahad H
Drug Res (Stuttg); 2016 Nov; 66(11):592-596. PubMed ID: 27643409
[No Abstract] [Full Text] [Related]
12. Effects of single nucleotide polymorphisms and haplotypes of the SLCO1B1 gene on the pharmacokinetic profile of atorvastatin in healthy Macedonian volunteers.
Daka A; Dimovski A; Kapedanovska A; Vavlukis M; Eftimov A; Labachevski N; Jakjovski K; Geshkovska MN; Nebija D; Mladenovska K
Pharmazie; 2015 Jul; 70(7):480-8. PubMed ID: 26373210
[TBL] [Abstract][Full Text] [Related]
13. Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy.
Hermann M; Bogsrud MP; Molden E; Asberg A; Mohebi BU; Ose L; Retterstøl K
Clin Pharmacol Ther; 2006 Jun; 79(6):532-9. PubMed ID: 16765141
[TBL] [Abstract][Full Text] [Related]
14. Enhanced hepatotoxicity and toxic outcome of thioacetamide in streptozotocin-induced diabetic rats.
Wang T; Fontenot RD; Soni MG; Bucci TJ; Mehendale HM
Toxicol Appl Pharmacol; 2000 Jul; 166(2):92-100. PubMed ID: 10896850
[TBL] [Abstract][Full Text] [Related]
15. SLCO1B1 polymorphism is not associated with risk of statin-induced myalgia/myopathy in a Czech population.
Hubáček JA; Dlouhá D; Adámková V; Zlatohlavek L; Viklický O; Hrubá P; Češka R; Vrablík M
Med Sci Monit; 2015 May; 21():1454-9. PubMed ID: 25992810
[TBL] [Abstract][Full Text] [Related]
16. Association of genetic variations with pharmacokinetics and lipid-lowering response to atorvastatin in healthy Korean subjects.
Woo HI; Kim SR; Huh W; Ko JW; Lee SY
Drug Des Devel Ther; 2017; 11():1135-1146. PubMed ID: 28435225
[TBL] [Abstract][Full Text] [Related]
17. Involvement of pregnane X receptor in the impaired glucose utilization induced by atorvastatin in hepatocytes.
Ling Z; Shu N; Xu P; Wang F; Zhong Z; Sun B; Li F; Zhang M; Zhao K; Tang X; Wang Z; Zhu L; Liu L; Liu X
Biochem Pharmacol; 2016 Jan; 100():98-111. PubMed ID: 26616219
[TBL] [Abstract][Full Text] [Related]
18. The hepatoprotective effect of the combination use of Fructus Schisandrae with statin--A preclinical evaluation.
Wat E; Ng CF; Wong EC; Koon CM; Lau CP; Cheung DW; Fung KP; Lau CB; Leung PC
J Ethnopharmacol; 2016 Feb; 178():104-14. PubMed ID: 26666731
[TBL] [Abstract][Full Text] [Related]
19. Decreased exposure of simvastatin and simvastatin acid in a rat model of type 2 diabetes.
Xu D; Li F; Zhang M; Zhang J; Liu C; Hu MY; Zhong ZY; Jia LL; Wang DW; Wu J; Liu L; Liu XD
Acta Pharmacol Sin; 2014 Sep; 35(9):1215-25. PubMed ID: 25152023
[TBL] [Abstract][Full Text] [Related]
20. Role of CYP3A in regulating hepatic clearance and hepatotoxicity of triptolide in rat liver microsomes and sandwich-cultured hepatocytes.
Shen G; Zhuang X; Xiao W; Kong L; Tan Y; Li H
Food Chem Toxicol; 2014 Sep; 71():90-6. PubMed ID: 24910460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
